# Abivax S.A.: Form SCHEDULE 13D/A, filed Feb 14, 2025

- Company: [Abivax S.A.](/companies/abvx.md) (CIK 1956827)
- Form: SCHEDULE 13D/A
- Filed: 2025-02-14
- Accepted by EDGAR: Feb 14, 2025, 16:19 ET
- Period: not reported
- Accession: 0001104659-25-014140
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1956827/000110465925014140/xslSCHEDULE_13D_X01/primary_doc.xml
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1956827/000110465925014140/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1956827/000110465925014140/xslSCHEDULE_13D_X01/primary_doc.xml

Filed Feb 14, 2025.
Source: SEC EDGAR, the filing index for accession 0001104659-25-014140. Last ingested by Listed: Oct 24, 2026, 15:16 ET. No prices; not investment advice.